FIELD: medicine. SUBSTANCE: described are new rapamycin esters of general formula I: wherein R1 is ; R2 is hydrogen or is as defined above for R1, and n is 8-200. Compounds are useful as immunosuppressive antiinflammatory, antifungal, antiproliferative and antitumor agent. EFFECT: improved properties of the title compound. 7 cl, 5 ex
Title |
Year |
Author |
Number |
C-22 STABILIZED DERIVATIVES OF RAPAMYCIN, METHOD OF IMMUNO- -SUPPRESSION INDUCING, METHOD OF TREATMENT AND PROPHYLAXIS OF TRANSPLANT REJECTION OR HOMOLOGOUS DISEASE, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERPROLIFERATIVE VASCULAR DISORDER |
1994 |
|
RU2152946C1 |
RAPAMYCIN 42-OXIMES AND HYDROXYLAMINES, METHOD OF SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENT |
1995 |
- Amedeo Arturo Failli
- Gaj Alan Shikhser
- Oleg Igorevich Blejman
|
RU2172316C2 |
RAPAMYCIN HYDROXYESTERS, METHOD OF THEIR SYNTHESIS AND METHODS OF TREATMENT |
1995 |
- Dzheral'D Stenli Skotnitski
- Kristina Luiza Leon
- Gaj Alan Shizer
|
RU2134267C1 |
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING |
1993 |
- Venling Kao
- Magid A.Abou-Gkharbia
- Robert L.Vogel
|
RU2126409C1 |
RAPAMYCIN PREPARATIONS FOR ORAL USING |
1998 |
|
RU2184541C2 |
AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]-INDOLE-8-ONE COMPOUNDS AND METHOD OF TREATMENT |
1996 |
- Stehk Gehri Pol
- M'Jusho Richard Ehrik
- Bravo Bajron Abel'
- Kang Jang Khi
|
RU2178416C2 |
TRIS-CARBAMIC ACID ESTERS, METHOD OF CHOLESTEROL ABSORPTION DECREASE, PHARMACEUTICAL COMPOSITION FOR CHOLESTEROL ABSORPTION DECREASE |
1994 |
- Tomas Dzhozef Kommons
- Donal'D Piter Strajk
- Krista Mari Ljakler
|
RU2130928C1 |
DERIVATIVES OF [([2- (AMINO -3,4-DIOXO -1-CYCLOBUTENE -1-YL)AMINO]ALKYL)] ACIDS |
1992 |
- Uil'Jam Alvin Kinni[Us]
- Dinna Kolett Garrison[Us]
|
RU2039035C1 |
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS |
1991 |
- Majkl Sotirios Malamas[Gr]
|
RU2110518C1 |
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Dzhon Vatson Ehllingboj
- Madelen Nikajdo
- Zhak Framros Bazhli
|
RU2113437C1 |